Dechra Veterinary Products has added a new webinar: 'Otitis Externa - Recent advances in the treatment of ears' to The Dechra Academy, the online training suite from Dechra Veterinary Products.
Presented by Sue Paterson, MA VetMB DVD DipECVD MRCVS RCVS & European Specialist in Veterinary Dermatology, the webinar accounts for 1.5 hours CPD and covers such topics as ear anatomy, cytology and the creation of treatment plans.
Carol Morgan, Dechra Brand Manager said: "We are dedicated to providing educational resources to support the veterinary profession. The otitis webinar is the latest addition to our range of high quality key-opinion-leader-led CPD on The Dechra Academy."
The webinar is now available to view on demand at www.dechra.co.uk/academy.
A new device call the Animalarm, which sends dog owners an SMS text message if the temperature in their car exceeds a preset threshold, has been launched this week.
Apparently, you can also ring the device to check what the temperature is inside your car.
The Animalarm sells for £108 inc. VAT from www.animalarm.co.uk.
Now all we need is a bit of sun.
Three veterinary surgeons and an appointed RCVS Councillor have been awarded an OBE in the Queen's Birthday Honours.
Caroline Freedman, who has been appointed to Council from the University of Edinburgh since 2005, received a British Empire Medal for services to animal welfare in Edinburgh. Caroline will be officially retiring from Council at RCVS Day on Friday 11 July but will remain as a lay member of the Practice Standards Group - the coordinating body for the Practice Standards Scheme.
Three veterinary surgeons were also awarded OBEs in the Queen's Birthday Honours. Sarah Cleaveland, Professor of Comparative Epidemiology at the University of Glasgow, was honoured for her contribution to veterinary epidemiology. Robert Houston, former Chief Veterinary Officer for Northern Ireland, was recognised for services to veterinary science in the country and Professor Julie Fitzpatrick, the Scientific Director of the Moredun Research Institute and Chief Executive of the Moredun Foundation, was honoured for services to animal health and science.
RCVS President Colonel Neil Smith said: "I am delighted to see these very deserving people from the veterinary world receive their due recognition in this year's Birthday Honours.
"During her time on Council Caroline has provided a greatly valued lay perspective on the veterinary issues of the day and I am pleased that she will continue to give her valuable insight to the organisation through the Practice Standards Group.
"Professor Cleaveland is our guest speaker at this year's RCVS Day where she will be speaking about her vital work in tackling zoonotic diseases on an international basis, so I am delighted to see that her contribution to human and animal health is being recognised.
"In addition, Bert Houston and Professor Fitzpatrick have contributed a great deal to both the veterinary profession and animal welfare in UK, with the latter being a member of our former Research Subcommittee."
The College’s PDP is a period of structured self-assessment, reflection and development designed to help veterinary graduates in the transition from life as a veterinary student to clinical practice.
During the PDP (which normally lasts no more than three years after the graduate enters clinical practice), graduates are supported by a Postgraduate Dean and are expected to keep a record of their clinical cases against a list of clinical skills and procedures, and reflect on how they are progressing in relation to the PDP Competences.
In 2016 BSAVA launched its online PDP Resource Bank, matched to the RCVS competences and created to provide BSAVA graduate members with CPD support during their first years in practice.
The research project, which is being conducted across the whole profession, aims to:
The RCVS and the BSAVA have now appointed the Work Psychology Group, to undertake the research. The research team also includes Professor Susan Rhind, from the Royal (Dick) School of Veterinary Studies, University of Edinburgh, and Professor Liz Mossop of the School of Veterinary Medicine and Science, University of Nottingham.
Christine Warman, Director of Education at the RCVS, said: "Since its launch in 2007 the PDP has had some success in helping graduates in the transition into practice life, but we recognise that there is some frustration and uncertainty with the process and that not everyone finds it helpful.
"So we are very pleased to be joining forces with the BSAVA on this project and hope it will help us get a better sense of how both graduates and employers feel about the PDP, where obstacles to learning and development exist, potential gaps in support provision and common areas of confusion, anxiety and concern."
Sheldon Middleton, BSAVA Honorary Treasurer and board sponsor of the BSAVA’s PDP Resource, said: "BSAVA recognised the gap in provision of support material for the professional skills element of the PDP and created the PDP Resource Bank to plug this gap for our members. We worked with the RCVS to match the resources to the structure of the PDP but also recognised that there was a need for support for employers of new graduates as well. The PDP Resource Bank is growing and has a dedicated editorial board reviewing material for inclusion. This research project will allow us to tailor our resource further and ensure our members are able to access the support they need.”
The research will be conducted across the whole veterinary profession through focus groups and telephone interviews and will include graduates, employers, vet school representatives, Postgraduate Deans, and BSAVA and British Veterinary Association (BVA) representatives. The results of the research will ultimately be made publicly available across the profession, together with recommendations for the further development of the PDP.
For more information about the PDP, visit www.rcvs.org.uk/pdp. You can find the BSAVA’s PDP Resource Bank at https://www.bsava.com/Education/PDP
The initiative comes after BEVA's new nurse committee ran a survey which found a poor understanding within the profession and amongst clients of what equine nurses can do.
Nurses said they believed they could be given more responsibility and do more within their roles and that there was a lack of opportunity for progression.
BEVA President David Rendle, who is championing this initiative, said: “RVNs are a significant an asset to any equine practice.
“They have invested a lot of time and effort to become highly skilled but in some instances their significant attributes are not being utilised to the full.
“Allowing RVNs to perform the clinical tasks that they are qualified to carry out under Schedule 3 of the Veterinary Surgeons Act 1966, will provide better job fulfilment and career development as well as free up veterinary surgeons to carry out other tasks, all increasing the efficiency of the veterinary team.
“I feel, and the RVN survey results would seem to confirm, that veterinary surgeons and practice managers do not appreciate how much veterinary nurses are allowed to do in equine practice.
"We all know veterinary nurses have the ability; look at what they do in small animal and human nursing, but we have felt unnecessarily constrained by Schedule 3 of the Veterinary Surgeons Act 1966 and the associated RCVS guidelines.
"If you actually look at Schedule 3 it is clear that we can and should be letting our qualified equine nurses do far more.
“There are so many things in equine practice that nurses do better than vets.
"In addition to performing clinical tasks they can add wider value; they are generally (or are perceived by clients to be!) more patient, empathetic and caring so we should utilise these skills and get nurses to take on some of the roles that take more time and require longer client interactions – discussing parasite control programmes, running weight loss clinics, reviewing healthcare plans, making follow-up phone calls and visits to name just a few.
"Nurses can take a lot of pressure off vets and can add a significant revenue stream for the practice.”
On the 9th February, the BEVA will be hosting an online discussion forum for all members of the practice team to discuss the role of nurses and how their skills, experience and knowledge can be better-used.
It's free for BEVA members: https://www.beva.org.uk/Home/Events/BEVA-Events/Event-Details.aspx?eventDateId=1716
Marie Rippingale Chair of the BEVA Nurse Committee said: “Last year’s recruitment and retention survey revealed that 50% of nurse respondents were earning less than £25,000 per annum and 48% of nurses said they were likely to look for a new job in the next two years.
"When asked their top reasons for leaving, salary was the biggest reason, and common themes on what would help the retention of nurses included salary, work-life balance and career progression.
“The review of Schedule 3 is important so we can encourage delegation of tasks to RVNs.
"This will allow RVNs to demonstrate their value and worth, earning money for the practice and achieving job satisfaction at the same time. This will contribute positively towards the current retention crisis.”
To find out more about what equine veterinary nurses can do in practice visit https://www.beva.org.uk/nurses
Photo: Liphook Equine Hospital.
The company points to data from the Animal Poison Control Center in the US which showed that in 2022, recreational drugs, including marijuana-based drugs, hallucinogenic mushrooms and cocaine made the list of top ten reasons for animals needing its help, knocking gardening products into 11th place.
In addition, the APCC reports a nearly 300% increase in calls about potential marijuana ingestion over the past five years
With this in mind, TVM has developed guidelines to support vets with these cases, both in terms of treatment options and tips on how to discuss the issue with clients and glean the information needed to help with the diagnosis and treat the animal.
TVM has also launched its new ‘Seasonal Suspects’ board kits to help vets educate pet owners on the common Christmas hazards commonly found around the house at this time of year.
The eye-catching waiting room display, which shows veterinary staff as seasonal superheroes, covers the dangers posed by items such as alcohol, batteries, plants and nuts, and advises pet owners on the necessary action needed should their pet digest any toxic substance.
TVM will also be sharing ‘Seasonal Suspects’ posts on its Facebook page for veterinary staff to share with their followers over Christmas.
For more information, email help@tvm-uk.com, call 0800 0385868 or contact your local Territory Manager.
To date most of these imaging procedures have been performed by vets within the group’s small animal first opinion veterinary practices.
The company says its Foundations in Diagnostic Imaging for Nurses training is designed to give its nurses more clinical stature in first opinion practice.
The programme will teach nurses the workings of an x-ray machine, common X-ray positions and contrast material.
It will also cover the principles of CT and MRI, showing how to set up and operate each piece of equipment, and how to support patients through these imaging procedures.
Finally, the course will provide the training nurses need to be able to perform ultrasounds within the current RCVS legal frameworks.
CVS says it believes this is a first in the veterinary profession
Tara Ryan, Chief Veterinary Nursing Officer at CVS said: “Imaging is a brand new area that we are starting to delegate to our nurses.
"Having heavily invested in our small animal first opinion practices over the last decade, we have a wide range of imaging equipment at many of our sites.
“Excitingly, this programme will open up the ability for nurses to start to contribute more information - to help vets identify and diagnose conditions and diseases in patients.
"It is another big step that we are taking to empower our brilliant nurses and to enable them to make a great clinical contribution towards the care of our patients – and to be the nurses they want to be.”
CVS is prioritising the consulting room and Schedule 3 delegated tasks as important areas for improving what it calls 'nurse optimisation'.
The company recognises that 'buy in' from veterinary surgeons is vital to the success of its efforts to optimise the role of its nurses, and the group has also published guidelines to provide clarity around effective delegation under Schedule 3.
Bimeda has announced the launch of a new teat seal which the company claims offers a significant return on investment and an opportunity for veterinary surgeons to prompt farmers to re-evaluate their dry cow therapy and mastitis control.
Bimeda's vet and head of technical services, Padraig Hyland MVB said: "Boviseal is proven to dramatically reduce mastitis in the 100 days post calving¹. Adding competition to the market will encourage farmers to re-assess their dry cow and mastitis strategies.
"The UK launch of Boviseal is a great opportunity for vets to raise the issue of the damage and cost of mastitis, and the potential savings by the correct use of a seal. Boviseal is the number one selling teat seal in the Republic of Ireland, with 2/3 of the Irish dairy cows sealed annually²."
Padraig says the evidence of the value from combined sealing and antibiotic therapy is all too clear when it comes to dry cow therapy. He cites a case study at Waterwheel Farm in Donegal, Ireland which delivered a 300% return on investment: "Combined therapy might sound costly but this two year study saw annual mastitis cases fall dramatically, from 26 per 100 cows to 9 per 100³.
"Defra figures indicate that mastitis is the most costly disease problem that UK dairy farmers face, with a typical case costing £175.00 4. When you compare that against the cost of treatment for the herd, there's no real counter argument in my opinion."
Boviseal contains 65% Bismuth Subnitrate. Padraig says the effectiveness of teat sealing is proven but correct administration is key: "It is important to note that the conventional practice of massaging into the udder after infusion is not employed - the teat seal must stay in the teat canal."
For details on best application practices, the company has developed a website, www.boviseal.co.uk with a video demonstration for correct infusion.
For further information, visit the website or contact Bimeda on 01248 725400.
References
Nigel Gibben said: "The Prevention Zone means anyone who keeps poultry such as chickens, ducks and geese, even as pets, must take action to stop them coming into contact with wild birds to protect them from avian flu.
"Birds should be moved into a suitable building, or if that isn’t possible owners must take sensible precautions to keep them away from wild birds, like putting up netting to create a temporary enclosure and keeping food and water supplies inside where they cannot be contaminated by wild birds.
"Even when birds are kept indoors a risk of infection remains so keepers must also practice good biosecurity, for example by disinfecting footwear and equipment and washing clothing after contact with birds.
"Recent H5N8 avian flu findings in wild birds and a backyard flock in Wales highlight just how essential it is to minimise contact between wild and captive birds and maintain good biosecurity to reduce the risk of infection.
"We must continue to be vigilant and do all we can to protect against this highly pathogenic strain of the disease, which is why we are extending the Prevention Zone, have introduced a ban on poultry gatherings and continue to strengthen surveillance to understand the extent of infection in wild birds."
Intervet/Schering-Plough Animal Health has announced that it has received approval for the intramuscular (IM) route of administration of Nuflor Minidose 450 mg/ml, a florfenicol-containing broad-spectrum antibiotic for the management of bovine respiratory disease (BRD).
Nuflor Minidose was approved initially in 2008 for subcutaneous (SC) use only and the now approved IM administration route is a line extension. According to Intervet/Schering Plough, IM administration (20 mg/kg administered twice, 48h apart) offers additional flexibility for the veterinary surgeon when treating cattle for BRD.
The company adds that Nuflor Minidose is the florfenicol injectable formulation which offers the lowest injection volume, which in particular is practical when treating heavier animals (thereby avoiding large injection volumes). The withdrawal period after IM administration of NUFLOR Minidose is only 37 days and is considerably shorter as compared to 64 days after SC use (40 mg/kg body weight injected once).
Francis Adriaens, Global Marketing Director, Global Ruminants Business Unit at Intervet/Schering-Plough Animal Health said: "Our customers requested the IM claim when Nuflor Minidose was first introduced and we are delighted to be able to recommend this route of administration hence forth."
Nuflor Minidose is indicated for preventive and therapeutic treatment of BRD in cattle caused by Mannheimia haemolytica, Pasteurella multicoda and Histophilus somni susceptible to florfenicol. The presence of the disease in the herd should be confirmed before administering preventive treatment.
A Market Harborough-based practice - Town & Country Veterinary Centre - has announced that it is entering a team into a 10km obstacle course race so gruelling it is called 'The Suffering'.
The Suffering takes place in the grounds of Rockingham Castle, Leicestershire, on Saturday 12 March 2016. It includes more than 25 water, mud and rope-based obstacles.
The Town & Country team, which includes vets, nurses, students and receptionists, hopes to raise £1,000 for Vets for Change, which is fundraising to vaccinate dogs in Africa against rabies.
Michael Lander MRCVS said: "We are big supporters of the work of Vets for Change which is currently fundraising for its next mass vaccination programme in South Africa. The race does sound gruelling and I have done no training as yet although some of my colleagues have been hitting the gym for the past couple of months. We will all pull together on the big day and getting everyone round the course is our goal.
"We'd be very grateful for donations to help us reach our target for Vets for Change which does such fantastic work and have set up a just giving page at https://crowdfunding.justgiving.com/townandcountry-veterinarycentre."
The team members are: Sarah Kay Robinson (Receptionist), Chloe Brown (Receptionist), Zara Lander (VN), Katy Kirkham (VN), Kathleen Gamble (VN), Grace Costall (Student VN), Kate Bodley (Small Animal Vet), Michael Lander (Small Animal Vet), Lucinda Ticehurst (Equine Vet).
The 'Tea-Time Training' webinar will be led by Animalcare’s Senior Veterinary Manager, Felicity Caddick.
Tea-Time Training was launched by Animalcare in April to support veterinary surgeons and nurses keep up their CPD. The webinars are short, free, refresher-style training sessions, designed to be enjoyed over a cup of tea.
Animalcare Product Manager James Beaumont said: “A missing microchipped pet is much more likely to be reunited with its owner than an animal which has not been microchipped. National Microchipping Month is a great opportunity for practices to remind clients of the benefits of microchipping and, in doing so, to strengthen their relationships with clients – relationships which are even more important given the difficult times we’re living through.”
To register for ‘4 Essentials for Successful Microchipping’, visit https://mailchi.mp/animalcare/tea-time-training.
To help veterinary practices engage with pet owners and help them understand the importance of eye health, TVM has produced a range of free educational materials including waiting room displays, informative web pages and social media packs.
The company has also published a page of information at www.tvm-uk.com/eyehealth – where pet owners can find out more about eye problems, how to spot them and learn what can be done about them.
Emma Hancox MRCVS, Veterinary Advisor at TVM said: "It can be easy for owners to miss the signs of problems with their pet’s eyes, but they can be extremely distressing for animals and be a sign of conditions ranging from cataracts and glaucoma through to conjunctivitis - all of which can be painful, and in the worst-case scenario, lead to blindness.
"We hope that National Pet Eye Health Awareness Week will help practices assist owners in understanding the importance of eye health and prevent more serious conditions occurring."
To request your board kit and pet owner leaflets, and download your free social media pack, visit www.tvm-uk.com/eyehealth or contact your Territory Manager.
The International Society of Feline Medicine (ISFM) has published 'Consensus Guidelines on the Long-term use of NSAIDs in cats' in the July 2010 edition of the Journal of Feline Medicine and Surgery.
The society says it has developed the guidelines in order to try and address the major welfare issue of cats suffering unremitting and untreated chronic pain. Until recently, NSAIDs had only been licensed for short-term use in cats, but with changing licensing indications and recommendations, they are now also increasingly used for long-term treatment of cats, for example in the management of osteoarthritis.
However, in most cases where long-term use of pain relief in cats is required, there are concomitant problems with other diseases or other drugs that are being given. According to the ISFM, one of the most common concerns is whether NSAIDs can be used to treat arthritis in older cats with kidney disease. The society says that because of concerns like these, and the potential for adverse effects, cats often receive no treatment at all, and their quality of life can be severely compromised.
For this reason, the ISFM set up an international expert panel to develop practical and rational guidelines on the long-term use of NSAIDs in cats. The aim was to provide guidelines that would empower clinicians, enabling them to make sensible and rational choices, and ensure much-needed therapy is not needlessly withheld from patients.
The panel was made up of Andrew Sparkes, Duncan Lascelles, Richard Malik, Sheilah Robertson, Margie Scherk, Polly Taylor, Llibertat Real Sampietro and Reidun Heiene.
Along with the veterinary information in the guidelines, the panel also developed a brief client-facing leaflet that can be given to owners when NSAIDs are prescribed for their cats - this leaflet provides simple, clear advice on why NSAIDs are used, why they are important, but also what simple precautions avoid adverse effects, with further advice on when to seek veterinary advice to reinforce the safety message.
Both of these publications are available to download from the website www.isfm.net/toolbox
Dechra Veterinary Products has launched a new Instruments and Consumables catalogue for veterinary professionals. The new catalogue is available to view online or download via Dechra's website at www.dechra.com
The new catalogue features the range of instruments and consumables available from Dechra, including a new wound dressing Silflex. This dressing is an atraumatic soft silicone contact layer, which minimises trauma at dressing change and protects delicate skin. Other products include Activon Medical Grade Manuka Honey dressings, Portex Jacksons cat catheters, Surgivet Slippery Sam cat catheters, ET tubes and 3M Vetrap bandaging tape.
The Dechra catalogue also includes help and advice for veterinary professionals, including step-by-step instructions for using some products and case studies for the range of wound dressings.
MSD Animal Health has launched a new Chronogest CR pack for practices starting a dialogue with sheep producer clients about planned breeding for 2013 lamb sales, and is offering a free applicator with every four packs purchased.
The Chronogest CR intra-vaginal sponges, impregnated with 20mg of cronolone (flugestone acetate) synthetic hormone, are now available in foil wrapped packs of 25. The packs protect the sponges from light and moisture.
MSD is reminding practitioners that sponging programmes must be planned at least six weeks in advance of mating, with PMSG-Intervet injections essential at sponge removal.
The new packs of 25 will be available when existing 25, 50 and 100 pack sizes sell out.
Further information on planned breeding - including newsletter copy and sheep producer advisory materials - is available from the MSD Animal Health veterinary support group (VSG) on 01908 685685 or via emailing vet-support.uk@merck.com
Petplan is running its television advertising campaign from now until October.
The advert (below) is airing on Sky 1, Sky Atlantic, ITV2, ITV3, More 4, Gold and USA.
Suzanne Cheadle, Acting Head of Marketing at Petplan said: "As the UK market leader, it is imperative that pet owners recognise and understand who we are and what we stand for. We need to help pet owners understand not only why pet insurance is so important, but explain why they should choose Petplan over any other provider. In 36 years, there's not an illness or accident that we haven't seen, and our Covered For Life policies have been developed with unrivalled knowledge and experience."
There are nine candidates standing in this year’s RCVS Council election, including five existing Council members eligible for re-election and four candidates not currently on Council. They are:
Dr Linda Belton MRCVS
Dr Niall Connell MRCVS
Mr John C Davies MRCVS
Dr Joanna (Jo) Dyer MRCVS
Professor Timothy (Tim) Greet FRCVS
Professor John Innes FRCVS
Dr Thomas (Tom) Lonsdale MRCVS
Dr Katherine (Kate) Richards MRCVS
Mr Peter Robinson MRCVS
Following the changes made to the College’s governance arrangements last year, after a Legislative Reform Order changing the size and composition of Council was passed by Parliament, there will be only three elected places available for the candidates, as opposed to six in the years prior to the governance changes.
Ballot papers and candidates' details are due to be posted and emailed to all veterinary surgeons eligible to vote during the week commencing 25 March, and all votes must be cast, either online or by post, by 5pm on Friday 26 April 2019.
In order to give the electorate a better idea of why each candidate is standing and ask them for their views on particular issues, this year the College is again inviting members of the profession to 'Quiz the candidates' by putting their questions directly to the candidates. Each candidate will be invited to choose two questions to answer from all those received, and produce a video recording of their answers.
Recordings will be published on the RCVS website and YouTube channel (www.youtube.com/rcvsvideos) on the week the election commences.
The biographies and statements for each candidate in the RCVS Council election can be found at www.rcvs.org.uk/vetvote19.
Vets should email their question (NB only one per person) to vetvote19@rcvs.org.uk or send it to the College’s Twitter account @theRCVS using the hashtag #vetvote19 by midday on Monday 4 March 2019.
They say that they've been aware of minor interruptions to the supply of such vaccines throughout 2022.
However, a significant, pan-European logistical problem being experienced by Boehringer Ingelheim has raised the prospect of a further reduction in supplies in the coming months.
BEVA is liaising with the three vaccine manufacturers to quantify the impact of the shortage and to consider solutions, both to minimise the threat to equine health and to prevent disruption to equestrian competition.
Marc Laemmer, equine business head at Boehringer Ingelheim Animal Health, said: “We are currently experiencing a European-wide supply issue relating to our equine influenza and influenza-tetanus vaccines.
"This has been caused by unexpected issues following the implementation of a technology upgrade and is not a product or quality issue.
"This means that some vet practices will have difficulty obtaining sufficient influenza vaccines and there may be a shortage in the UK market.
"We understand the importance of these vaccines to equine welfare, and we are continuing to work tirelessly to find a solution so that we can return to normal supply as soon as possible.”
Amanda Melvin, equine business manager at MSD Animal Health, said: “Based on prior demand, MSD’s equine vaccines Equilis Prequenza and Equilis Prequenza Te are in full supply.
"MSD have taken steps to protect as many horses as possible at this time.
"We will continue to supply existing customers with the available MSD stock on ‘allocation’ and, where possible, to allocate stock to additional customers. Allocations are being made to our veterinary customers based on their historical demand which we believe is the most efficient way to manage the available supplies.”
Rebecca Cabrejas, equine business unit manager at Zoetis, said: “Demand for our vaccines currently exceeds what we can supply.
"Whilst we have adequate stocks to fulfil current customers’ orders unfortunately, we are not in a position to be able to supply new customers at this time.
"We will continue to work with BEVA to limit the impact of the current shortages.”
For practices planning to take part in National Microchipping Month, Virbac is providing a personalised poster design service and chip promotion throughout June.
According to product manager Gillian Brown, the idea is to offer additional tailored support to practices during the promotional period: "Obviously many practices will have National Microchipping Month materials in place, but the price each practice offers their clients is individual to them. These posters provide a visual platform to highlight the promotion.
"To take advantage of the scheme, practices just need to notify their territory manager of the price they propose to charge and we will then manage the design and print."
Virbac will also be offering a promotional chip price in June to support National Microchipping Month. Gillian said: "Microchipping is now the official means of pet identification approved by the EU Pet Passport Scheme. This will help practices provide an attractive promotion to pet owners and hopefully encourage greater up-take of microchipping."
Any practice interested in the initiative should contact their local Virbac territory manager or call Virbac on 01379 243243.
Vétoquinol has launched Flexadin, a new range of joint support products for cats and dogs with osteoarthritis (OA)
Robert Simpson, Flexadin Product Manager said: "This new range is made up of two products: Flexadin Plus and Flexadin Advanced, both are dietetic complementary feeds which are members of a small group of joint support products which contain Omega-3 fatty acids and Vitamin E. These ingredients are proven to aid the support of the metabolism of joints in the case of OA. Although many different joint support aids are available, not all of them contain these extra ingredients."
Vétoquinol says that in addition to Omega-3 fatty acids and Vitamin E, Flexadin Plus contains the traditional ingredients: glucosamine, chondroitin and devil's claw. Flexadin Advanced contains the novel ingredient, UCII - a type of undenatured type II collagen which has been manufactured using a patented process.
Flexadin Plus comes in two formulations, the first is specifically designed for cats/small dogs and the other is for medium/large dogs. Flexadin Advanced is specifically for dogs.
Robert added: "Flexadin Advanced has a specific property which means that the administration rate is only one chew per day whatever the weight of the dog. This has an important impact on the price per day for medium and large dogs which may require more than one tablet of traditional joint support products. This property also makes Flexadin Advanced a convenient option for owners. In addition to this benefit, UCII is becoming more and more popular due to the results of scientific studies in dogs, horses and even humans.
"We are all very excited about the advances this range can bring to veterinary practices."
Both Flexadin Plus and Advanced are presented as palatable, shaped, soft chews which come in zip-lock packs to keep the soft chews fresh and tasty. Flexadin Plus comes in packs of 90 chews whilst Flexadin Advanced comes in packs of 30 chews.
For further information about Flexadin, contact Vétoquinol on: 01280 825424.
The Animal Health Trust is appealing to veterinary surgeons and nurses to encourage clients who keep their horses on premises that have been affected by Equine Grass Sickness to sign up to the second year of its nationwide EGS vaccine trial.
Equine Grass Sickness (EGS) occurs predominantly in Europe, with Britain experiencing the highest incidence worldwide. In 2014, 59 cases of EGS were reported through the EGS Surveillance Scheme, but it is likely that this represents only a fraction of cases occurring annually throughout Britain.
Almost all cases of EGS occur in horses with access to grazing. The AHT says there is growing scientific evidence to suggest that the disease may be caused by the bacterium Clostridium botulinum type C, commonly found within soil and capable of producing neurotoxins to which horses are particularly sensitive. EGS occurs when a combination of risk factors trigger the production of these toxins within the horse's intestinal tract, causing damage to the nervous system and paralysis of the gut.
As similar equine diseases such as tetanus and botulism can be prevented by vaccination, it is theoretically possible that a vaccine could prevent EGS. To this end the AHT, in collaboration with the Universities of Edinburgh, Liverpool and Surrey launched the EGS field vaccine trial in 2014 in order to establish whether a vaccine could indeed be effective in reducing the risk of the disease. The trial is funded by a number of sources including Neogen Corporation; Animal Welfare Foundation; Horserace Betting Levy Board; Racing Foundation; Moredun Foundation Equine Grass Sickness Fund; Hong Kong Jockey Club; The British Horse Society and the EB Moller Charitable Trust.
Now entering its second year, the EGS vaccine trial involves enrolled horses and ponies receiving either a course of the C. botulinum type C toxoid vaccine or an inactive placebo, as well as an annual booster. The incidence of EGS is monitored throughout the trial to determine the efficacy of the vaccine, and enrolled horses and ponies are closely monitored through regular follow-ups for the duration of the trial.
With 60% of EGS cases occurring during April - June, the highest risk season for EGS is fast approaching. The AHT is appealing to owners who keep their horses on premises that have had at least one case of EGS in the past three years to enrol their horse in the vaccine trial and provide an invaluable contribution to this pioneering research prior to these high risk months. Veterinary practices with clients who fit this description are asked to help the recruitment process by encouraging suitable cases to sign up to the trial.
Dr Jo Ireland, the AHT's Equine Grass Sickness Research Co-ordinator, said: "We have been delighted with the overwhelmingly positive response to the EGS vaccine trial and many owners have welcomed the chance to be a part of such important research. We don't want any eligible horse owners to miss out on the opportunity to contribute towards a potential breakthrough in the prevention of EGS, so we are encouraging more owners to enrol their horses on the trial this year."
To find out more about the vaccine trial or how clients can enrol horses and ponies, visit the AHT's dedicated EGS website www.equinegrasssickness.co.uk or email equinegrasssickness@aht.org.uk.
The charity will be carrying out a study about the disease in collaboration with the Universities of Liverpool and Nottingham. However, because funding for research is limited, and because researchers want it to answer questions around PPID that owners and veterinary surgeons actually want to know, they are asking for your suggestions.
The AHT says that it wants to provide owners and vets with practical and applicable advice that will improve the wellbeing of their horses, based on scientific evidence. So whether that’s a question around how the disease is diagnosed, the best way to treat it or what the long term prognosis is, now is your chance to have your say.
If you own or care for a horse/pony with PPID or are a veterinary surgeon that treats them (or you have done in the past) please visit: www.aht.org.uk/PPID, to take part.
If you have any questions, contact the Project Investigator Becky Tatum by email: becky.tatum @aht.org.uk or by telephone: 01638 751000 Ext. 1241
HSR, which provides emergency and routine specialist orthopaedic and neurology services, now offers video consultations with a specialist and a pet transportation service. It has also introduced strict strict biosecurity and operational preventative measures.
Clare Hamilton, Managing Director, says, “Our priority is to continue to offer gold-standard service for both routine and emergency orthopaedic and neurological cases whilst doing our utmost to limit the spread of Covid-19 as much as possible. We are to all intents and purposes, ‘business as usual’ with additional hygiene measures to protect clients and staff”.
HSR is asking clients that if there is a chance that they have Covid-19 and/or have come into contact with anyone with the virus they do not attend the hospital in person, but instead contact via email or telephone to discuss their pet’s treatment on an individual basis. Clients visiting the clinic are being asked to wait in their cars until their appointment, whereupon the animal is collected from the car by one of the team for its clinical examination. The vets are then speaking to the clients by telephone to discuss and gain consent for any further investigation or treatment.
For vulnerable clients who are self-isolating and in need of their services, HSR is offering a pet ambulance service for collection and drop off of pets. They will then have a video consultation with the specialist. Medications will be posted out and advice given over email or telephone.
Clare added: “We are doing all we can to support colleagues and clients in what are unprecedented circumstances. We recognise the strain on many practices having to reduce the number of appointments in the face of staff shortages. We want to reassure vets that we are happy to offer advice and support with cases, and continue to take referrals during this difficult period. We also have free online CPD for practices via our website as meetings are postponed or cancelled”.
The practice advises clients and referring vets to check for further developments on social media, or sign up to their email list for updates.
The Disciplinary Committee of the Royal College of Veterinary Surgeons has refused an application for restoration to the RCVS Register from a Kent-based former veterinary surgeon struck off in 1994 for disregarding basic hygiene at his professional premises and failing to properly maintain a Controlled Drugs Register or patient records.
In June 1994, the Committee found that Mr Warwick John Seymour-Hamilton, at that time the only veterinary surgeon practising at premises at 9 Orchard Grove, Orpington, Kent, was guilty of disgraceful professional conduct and should have his name removed from the Register. The state and condition of the premises were found to be such as to risk the health and welfare of animals taken to the premises, and bring the profession into disrepute. An application made by Mr Seymour-Hamilton for restoration made in 1995 was refused.
At a restoration hearing on 18 June 2010, Mr Seymour-Hamilton told the Committee that he sought restoration to the Register because he wished to further his research work into plants with potential medicinal properties. Restoration, he said, would improve his professional status by giving him more credibility, particularly in terms of recognition by the medical and veterinary professions.
Mr Seymour-Hamilton said that he had no intention of returning to clinical practice immediately, and neither the Committee nor the College had heard of any adverse conduct by the applicant since his removal.
However, Caroline Freedman, Chairman of the Disciplinary Committee, noted that if Mr Seymour-Hamilton were to be restored, the Committee would have no power to prevent him from returning to general practice.
Mr Seymour-Hamilton's response to questioning by the Committee raised a number of concerns with respect to the future welfare of animals should restoration be granted. He told the Committee that he had not undertaken any relevant Continuing Professional Development in the past 15 years, and said he lacked knowledge of current relevant legislation, for example, the Animals (Scientific Procedures) Act 1986 and basic 'Cascade' prescribing requirements. He also said that he had not read the RCVS Guide to Professional Conduct in the past 15 years and that it would not be satisfactory for him immediately to return to general practice.
Ms Freedman said: "If the Committee were to reinstate the Applicant to the Register, it would have to be satisfied that he is competent and safe to practise immediately. The Committee has an obligation to protect the public and animal welfare and cannot simply accept his assurances that he would take steps to rectify his self-confessed shortcomings at some point in the future."
Having taken all the evidence presented into account, the Committee was not satisfied that Mr Seymour-Hamilton was fit to be restored to the Register and dismissed his application.